Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens

Bacteriocins are antimicrobial peptides with relevance in the modulation of human and animal microbiota that have gained interest in biomedical and biotechnological applications. In this study, the production of bacteriocin-like inhibitory substances (BLIS) was tested among a collection of 890 staph...

Full description

Bibliographic Details
Main Authors: Rosa Fernández-Fernández, Carmen Lozano, Paula Eguizábal, Laura Ruiz-Ripa, Sandra Martínez-Álvarez, Idris Nasir Abdullahi, Myriam Zarazaga, Carmen Torres
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.870510/full
_version_ 1817991540790788096
author Rosa Fernández-Fernández
Carmen Lozano
Paula Eguizábal
Laura Ruiz-Ripa
Sandra Martínez-Álvarez
Idris Nasir Abdullahi
Myriam Zarazaga
Carmen Torres
author_facet Rosa Fernández-Fernández
Carmen Lozano
Paula Eguizábal
Laura Ruiz-Ripa
Sandra Martínez-Álvarez
Idris Nasir Abdullahi
Myriam Zarazaga
Carmen Torres
author_sort Rosa Fernández-Fernández
collection DOAJ
description Bacteriocins are antimicrobial peptides with relevance in the modulation of human and animal microbiota that have gained interest in biomedical and biotechnological applications. In this study, the production of bacteriocin-like inhibitory substances (BLIS) was tested among a collection of 890 staphylococci of different origins (humans, animals, food, and the environment) and species, both coagulase-positive (CoPS, 238 isolates of 3 species) and coagulase-negative staphylococci (CoNS, 652 isolates of 26 species). Of the 890 staphylococci, 60 (6.7%) showed antimicrobial activity by the spot-on-lawn method against at least one of the 25 indicator bacteria tested. BLIS-producer (BLIS+) isolates were detected in 8.8% of CoPS and 6.0% of CoNS. The staphylococcal species with the highest percentages of BLIS+ isolates were S. chromogenes (38.5%), S. pseudintermedius (26.7%), and S. warneri (23.1%). The production of BLIS was more frequently detected among isolates of pets, wild animals, and food. Moreover, 13 BLIS+ isolates showed wide antimicrobial activiy spectrum, and 7 of these isolates (of species S. aureus, S. pseudintermedius, S. sciuri, and S. hominis) demonstrated antimicrobial activity against more than 70% of the indicator bacteria tested. The genetic characterization (by PCR and sequencing) of the 60 BLIS+ isolates revealed the detection of (a) 11 CoNS and CoPS isolates carrying putative lantibiotic-like genes; (b) 3 S. pseudintermedius isolates harboring the genes of BacSp222 bacteriocin; and (c) 2 S. chromogenes isolates that presented the gene of a putative cyclic bacteriocin (uberolysin-like), being the first report in this CoNS species. Antimicrobial susceptibility testing was performed in BLIS+ isolates and one-third of the CoNS isolates showed susceptibility to all antibiotics tested, which also lacked the virulence genes studied. These BLIS+ CoNS are good candidates for further characterization studies.
first_indexed 2024-04-14T01:14:43Z
format Article
id doaj.art-1d7050ee694449b1b8adafb6b3a55d49
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-14T01:14:43Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-1d7050ee694449b1b8adafb6b3a55d492022-12-22T02:20:53ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-04-011310.3389/fmicb.2022.870510870510Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant PathogensRosa Fernández-FernándezCarmen LozanoPaula EguizábalLaura Ruiz-RipaSandra Martínez-ÁlvarezIdris Nasir AbdullahiMyriam ZarazagaCarmen TorresBacteriocins are antimicrobial peptides with relevance in the modulation of human and animal microbiota that have gained interest in biomedical and biotechnological applications. In this study, the production of bacteriocin-like inhibitory substances (BLIS) was tested among a collection of 890 staphylococci of different origins (humans, animals, food, and the environment) and species, both coagulase-positive (CoPS, 238 isolates of 3 species) and coagulase-negative staphylococci (CoNS, 652 isolates of 26 species). Of the 890 staphylococci, 60 (6.7%) showed antimicrobial activity by the spot-on-lawn method against at least one of the 25 indicator bacteria tested. BLIS-producer (BLIS+) isolates were detected in 8.8% of CoPS and 6.0% of CoNS. The staphylococcal species with the highest percentages of BLIS+ isolates were S. chromogenes (38.5%), S. pseudintermedius (26.7%), and S. warneri (23.1%). The production of BLIS was more frequently detected among isolates of pets, wild animals, and food. Moreover, 13 BLIS+ isolates showed wide antimicrobial activiy spectrum, and 7 of these isolates (of species S. aureus, S. pseudintermedius, S. sciuri, and S. hominis) demonstrated antimicrobial activity against more than 70% of the indicator bacteria tested. The genetic characterization (by PCR and sequencing) of the 60 BLIS+ isolates revealed the detection of (a) 11 CoNS and CoPS isolates carrying putative lantibiotic-like genes; (b) 3 S. pseudintermedius isolates harboring the genes of BacSp222 bacteriocin; and (c) 2 S. chromogenes isolates that presented the gene of a putative cyclic bacteriocin (uberolysin-like), being the first report in this CoNS species. Antimicrobial susceptibility testing was performed in BLIS+ isolates and one-third of the CoNS isolates showed susceptibility to all antibiotics tested, which also lacked the virulence genes studied. These BLIS+ CoNS are good candidates for further characterization studies.https://www.frontiersin.org/articles/10.3389/fmicb.2022.870510/fullbacteriocinmultidrug resistant (MDR) bacteriaBLIScoagulase-negative staphylococcicoagulase-positive staphylococci
spellingShingle Rosa Fernández-Fernández
Carmen Lozano
Paula Eguizábal
Laura Ruiz-Ripa
Sandra Martínez-Álvarez
Idris Nasir Abdullahi
Myriam Zarazaga
Carmen Torres
Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
Frontiers in Microbiology
bacteriocin
multidrug resistant (MDR) bacteria
BLIS
coagulase-negative staphylococci
coagulase-positive staphylococci
title Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
title_full Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
title_fullStr Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
title_full_unstemmed Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
title_short Bacteriocin-Like Inhibitory Substances in Staphylococci of Different Origins and Species With Activity Against Relevant Pathogens
title_sort bacteriocin like inhibitory substances in staphylococci of different origins and species with activity against relevant pathogens
topic bacteriocin
multidrug resistant (MDR) bacteria
BLIS
coagulase-negative staphylococci
coagulase-positive staphylococci
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.870510/full
work_keys_str_mv AT rosafernandezfernandez bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT carmenlozano bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT paulaeguizabal bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT lauraruizripa bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT sandramartinezalvarez bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT idrisnasirabdullahi bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT myriamzarazaga bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens
AT carmentorres bacteriocinlikeinhibitorysubstancesinstaphylococciofdifferentoriginsandspecieswithactivityagainstrelevantpathogens